Myocardial circulatory and metabolic effects of halothane when used to control intraoperative hypertension in patients with coronary artery disease.
Sahlman
L
L
Department of Anesthesia and Intensive Care, Sahlgren's Hospital, Gothenburg, Sweden.
Milocco
I
I
Ricksten
S E
SE
D000769:Anesthesia, Inhalation; D001794:Blood Pressure / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects*; D003327:Coronary Disease / Q000601:surgery*; D006221:Halothane / Q000494:pharmacology*; D006801:Humans; D006973:Hypertension / Q000517:prevention & control*; D007431:Intraoperative Complications / Q000517:prevention & control*; D007773:Lactates / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D011669:Pulmonary Wedge Pressure / Q000187:drug effects; D013249:Sternum / Q000601:surgery; D013908:Thoracotomy; D014655:Vascular Resistance / Q000187:drug effects
D007773:Lactates; D006221:Halothane